Education
About Us
Working with TipRanks
Follow Us
Nanosonics Limited (NNCSF)
OTHER OTC:NNCSF
NNCSF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.67 - $3.05
Previous CloseN/A
Volume26.00
Average Volume (3M)96.00
Market Cap
$957.65M
Enterprise Value$812.43M
Total Cash (Recent Filing)AU$99.28M
Total Debt (Recent Filing)AU$11.45M
Price to Earnings (P/E)76.4
Beta0.23
Next Earnings
Sep 01, 2025EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding303,590,970
10 Day Avg. Volume0
30 Day Avg. Volume96
Financial Highlights & Ratios
PEG Ratio18.88
Price to Book (P/B)N/A
Price to Sales (P/S)11.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.10Price Target Upside12.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
---
Nanosonics Limited News
PremiumCompany Announcements
Nanosonics Secures FDA Clearance for CORIS® System
PremiumCompany Announcements
Nanosonics Director Increases Shareholding, Signaling Confidence
PremiumCompany Announcements
Nanosonics Limited Announces Quotation of New Securities
PremiumCompany Announcements
Nanosonics Updates on Director’s Interest Notice
PremiumCompany Announcements
Nanosonics Corrects Security Classification Error in Recent Announcement
PremiumCompany Announcements
Nanosonics Director Acquires 20,000 SharesPremiumCompany Announcements
Nanosonics Director Increases Stake in Company---
Options Prices
Currently, No data available
---
Ownership Overview
0.58% Insiders
2.75% Mutual Funds
0.03% Other Institutional Investors
94.13% Public Companies and
Individual Investors
NNCSF FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest stock price was $1.67 and its highest was $3.05 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is $957.65M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Sep 01, 2025 which is in 160 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Feb 19, 2025. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.014 by $0.006.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.02.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 303,590,970 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of $0.02 in its last earnings report, beating expectations of $0.014. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in NNCSF
---
Nanosonics Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.10 (12.73% Upside)
$3.10 (12.73% Upside)
Blogger Sentiment
Bullish
NNCSF Sentiment 83%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $121.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.49%
12-Months-Change
Fundamentals
Return on Equity
9.23%
Trailing 12-Months
Asset Growth
1.89%
Trailing 12-Months
Company Description
Nanosonics Limited
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
---
NNCSF Company Deck
---
NNCSF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive performance with substantial revenue growth, particularly in North America and Europe. While challenges exist in European installations and regulatory delays in Japan, the company's financial health and strategic region-focused growth remain strong.Read More>---
NNCSF Stock 12 Month Forecast
Average Price Target
$3.10
▲(12.73% Upside)
Technical Analysis
Cochlear Limited
―
CSL
―
Fisher & Paykel Healthcare Corporation Limited
―
Ramsay Health Care
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering NNCSF
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+8.00%
downgraded a sell rating 6 days ago
Copying David Low's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +8.00% per trade.
---